Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.50    -0.01 (-0.66%)
Bid:
1.50
Ask:
1.88
Spread: 0.38 (25.333%)
Market Cap: £5.26m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

30 Sep 2014 07:00

RNS Number : 9286S
Proteome Sciences PLC
30 September 2014
 



 

 

 

 

 

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of new Finance Director

 

30th September, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Geoffrey Ellis as Finance Director with effect from 1st October. Mr. Geoffrey John Ellis, 53, is a chartered accountant with over 30 years' experience in a range of senior financial, operational, sales and business development roles. He spent 15 years at Walt Disney where he was Chief Financial Officer of the Network of Disney Channels in EMEA and Managing Director of Disney Chanel Scandinavia, Middle East and Emerging Markets.

In addition to a strong financial background, he brings considerable international sales, marketing and licensing expertise and a key part of his role will be managing and expanding our commercial sales and marketing in USA and Europe.

Mr. James Malthouse will remain as a director of the company until his retirement on 30th November, 2014.

Mr. Ellis was a director of Curzon ISC Limited until shortly before it was placed into voluntary liquidation in March 2011. He was also a director of Warren Close Residents Association (Esher) Limited at the time it was placed into voluntary liquidation in May 2013.

Other than disclosed above, the Company confirms that there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065

James Malthouse, Finance Director

 

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly /Callum Davidson Tel: +44 (0)20 7397 8900

 

finnCap - Joint Broker

Geoff Nash (Corporate Finance) Tel: +44 (0)20 7220 0500

Tony Quirke (Broking)

 

IKON Associates - Public Relations

Adrian Shaw Tel: +44 (0)1483 271291

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVKLFLZKFFBBX
Date   Source Headline
10th Oct 20073:31 pmPRNNotifiable Interest
8th Oct 20072:34 pmPRNStatement regarding mailing of interim report
2nd Oct 20074:28 pmPRNDirectorate Change
28th Sep 20078:00 amPRNInterim Results
21st Sep 20079:54 amPRNPress Release re Intronn Inc.
6th Sep 20074:27 pmPRNNotifiable Interest
17th Aug 20076:15 pmPRNAIM Rule 26 & Adviser Name
30th Jul 20077:00 amPRNStatement re US Patent Allowed
25th Jul 200712:03 pmPRNDirector's Dealing
12th Jul 20072:58 pmPRNNotifiable Interest
2nd Jul 20074:59 pmPRNDirector/PDMR Shareholding
29th Jun 20078:15 amPRNFurther Loan Agreement
29th Jun 20078:00 amPRNFinal Results
22nd May 20073:50 pmPRNNotifiable Interest
15th May 200711:38 amPRNGrant of European Patent
14th May 200711:40 amPRNNotifiable Interest
10th May 20075:03 pmPRNNotifiable Interest
8th May 20078:30 amPRNNotice of Allowance of TMT1 Patent in Canada
25th Apr 20073:32 pmPRNBlocklisting - Interim Review
20th Apr 200711:03 amPRNDirector's Dealings
19th Apr 20072:26 pmPRNNotifiable Interest
18th Apr 20078:30 amPRNService Agreement with Onconome Inc.
13th Apr 200712:20 pmPRNNotifiable Interest
13th Apr 200712:13 pmPRNNotifiable Interest
21st Mar 20077:00 amPRNHolding(s) in Company
21st Mar 20077:00 amPRNHolding(s) in Company
21st Mar 20077:00 amPRNHolding(s) in Company
21st Feb 20079:41 amPRNPress Release
19th Feb 20074:40 pmPRNHolding(s) in Company
15th Jan 20077:00 amPRNStatement re Issuance of Patent
5th Jan 200712:29 pmPRNHolding(s) in Company
21st Dec 20064:59 pmPRNHolding(s) in Company
18th Dec 20062:12 pmPRNStatement re: Patent
13th Dec 20062:07 pmPRNStatement re Issuance of Patent
13th Dec 200611:32 amPRNTotal Voting Rights
11th Dec 200610:49 amPRNStatement re: Issuance of Patent
31st Oct 200612:42 pmPRNHolding(s) in Company
30th Oct 20065:38 pmPRNBlocklisting
5th Sep 20069:54 amPRNDirectorate Change
27th Jul 20061:53 pmPRNHolding(s) in Company
27th Jul 200612:04 pmPRNResult of AGM
18th Jul 20067:00 amPRNAppointment
17th Jul 20064:41 pmRNSSecond Price Monitoring Extn
17th Jul 20064:36 pmRNSPrice Monitoring Extension
6th Jul 20065:12 pmPRNHolding(s) in Company
4th Jul 20064:42 pmRNSSecond Price Monitoring Extn
4th Jul 20064:36 pmRNSPrice Monitoring Extension
29th Jun 20062:00 pmPRNFinal Results
28th Jun 20064:42 pmRNSSecond Price Monitoring Extn
28th Jun 20064:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.